REGENERON PHARMACEUTICALS, INC. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for November 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 10,000 | 520,300 | 88,079 | |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 365.41 | 300 | 109,623 | 22,455 | 22.8 K to 22.5 K (-1.32 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 364.20 | 2,284 | 831,833 | 22,755 | 25 K to 22.8 K (-9.12 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 363.58 | 1,422 | 517,011 | 25,039 | 26.5 K to 25 K (-5.37 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 362.75 | 5,994 | 2,174,324 | 26,461 | 32.5 K to 26.5 K (-18.47 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 10,000 | 520,300 | 32,455 | 22.5 K to 32.5 K (+44.53 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.25 | 46,138 | 980,433 | 107,655 | |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 764 | 0 | 144,897 | 145.7 K to 144.9 K (-0.52 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 669 | 0 | 145,661 | 146.3 K to 145.7 K (-0.46 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 366.63 | 4,517 | 1,656,068 | 304,485 | 309 K to 304.5 K (-1.46 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 365.25 | 3,269 | 1,194,002 | 309,002 | 312.3 K to 309 K (-1.05 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 364.55 | 3,755 | 1,368,885 | 312,271 | 316 K to 312.3 K (-1.19 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 363.53 | 3,605 | 1,310,526 | 316,026 | 319.6 K to 316 K (-1.13 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 362.61 | 2,284 | 828,201 | 319,631 | 321.9 K to 319.6 K (-0.71 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 361.46 | 2,492 | 900,758 | 321,915 | 324.4 K to 321.9 K (-0.77 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 360.37 | 592 | 213,339 | 324,407 | 325 K to 324.4 K (-0.18 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 359.46 | 1,479 | 531,641 | 324,999 | 326.5 K to 325 K (-0.45 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 358.92 | 156 | 55,992 | 326,478 | 326.6 K to 326.5 K (-0.05 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 22,093 | 0 | 326,634 | 348.7 K to 326.6 K (-6.34 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 14,000 | 0 | 348,727 | 362.7 K to 348.7 K (-3.86 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 358.33 | 23,989 | 8,595,978 | 362,727 | 386.7 K to 362.7 K (-6.20 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.25 | 46,138 | 980,433 | 386,716 | 340.6 K to 386.7 K (+13.55 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 7,246 | 0 | 340,578 | 347.8 K to 340.6 K (-2.08 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 40,681 | 0 | 347,824 | 388.5 K to 347.8 K (-10.47 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 1,000 | 33,420 | 3,000 | |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 1,000 | 33,420 | 4,000 | |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 360.00 | 1,000 | 360,000 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 1,000 | 33,420 | 11,323 | 10.3 K to 11.3 K (+9.69 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 350.00 | 1,000 | 350,000 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 1,000 | 33,420 | 11,323 | 10.3 K to 11.3 K (+9.69 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 273.67 | 4,500 | 1,231,515 | 6,250 | |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Gift | G | 0.00 | 1,000 | 0 | 11,349 | 12.3 K to 11.3 K (-8.10 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 349.00 | 4,500 | 1,570,500 | 323 | 4.8 K to 323 (-93.30 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 273.67 | 4,500 | 1,231,515 | 4,823 | 323 to 4.8 K (+1,393.19 %) |
Nov 08 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 340.44 | 1,000 | 340,440 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |